Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19
The COVID-19 pandemic needs no introduction at present. Only a few treatments are available for this disease, including remdesivir and favipiravir. Accordingly, the pharmaceutical industry is striving to develop new treatments for COVID-19. Molnupiravir, an orally active RdRp inhibitor, is in a phas...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
MDPI AG
2021-09-01
|
| 丛编: | Molecules |
| 主题: | |
| 在线阅读: | https://www.mdpi.com/1420-3049/26/19/5795 |